BioCardia (BCDA) Current Leases (2019 - 2026)
BioCardia's (BCDA) quarterly Current Leases came in at $293000.0 in Q2 2026, down 28.88% year-over-year from $412000.0 in Q2 2025, and down 28.88% quarter-over-quarter from $412000.0 in Q1 2026.
Powered by 
Analysis
BioCardia (BCDA) Current Leases (2019 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Current Leases for 8 consecutive years, with $293000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Leases fell 28.88% year-over-year to $293000.0 in Q2 2026; TTM through Jun 2026 was $293000.0, a 28.88% decrease from a year earlier, with the FY2025 full-year figure at $442000.0, up 14.81% from the prior year.
- Current Leases was $293000.0 for Q2 2026 at BioCardia, down from $412000.0 in the prior quarter.
- Over five years, Current Leases peaked at $442000.0 in Q4 2025 and troughed at $281000.0 in Q1 2022.
- A 5-year average of $353111.1 and a median of $342500.0 in 2023 frame the typical range for Current Leases.
- The widest YoY moves for Current Leases: up 88.82% in 2022, down 39.96% in 2022.
- Over 5 years, Current Leases stood at $315000.0 in 2022, then climbed by 5.71% to $333000.0 in 2023, then advanced by 15.62% to $385000.0 in 2024, then grew by 14.81% to $442000.0 in 2025, then sank by 33.71% to $293000.0 in 2026.
- The last three Current Leases figures came in at $293000.0 (Q2 2026), $412000.0 (Q1 2026), and $442000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 1.81 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 18.65 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 2.67 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 2.99 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 15.21 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 1.06 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 14.16 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 293,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 293,000.00 |
| Mar 31, 2026 | 412,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Sep 30, 2025 | 427,000.00 |
| Jun 30, 2025 | 412,000.00 |
| Mar 31, 2025 | 398,000.00 |
| Dec 31, 2024 | 385,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Jun 30, 2024 | 358,000.00 |
| Mar 31, 2024 | 345,000.00 |
| Dec 31, 2023 | 333,000.00 |
| Sep 30, 2023 | 321,000.00 |
| Jun 30, 2023 | 340,000.00 |
| Mar 31, 2023 | 327,000.00 |
| Dec 31, 2022 | 315,000.00 |
| Sep 30, 2022 | 304,000.00 |
| Jun 30, 2022 | 292,000.00 |
| Mar 31, 2022 | 281,000.00 |
| Dec 31, 2021 | 237,000.00 |
| Sep 30, 2021 | 161,000.00 |